Student Research
Papers
GENE 225:
Healthcare
Venture Capital
Instructors for this course:
Michael Snyder, PhD
Stanford W. Ascherman, MD, FACS, Professor in Genetics
Ronjon Nag, PhD
Adjunct Professor in Genetics, Stanford School of Medicine
Director, R42 Longevity Fund
Artem Trotsyuk, PhD
Principal, R42 Fund, Teaching Assistant, AI Ethics Postdoctoral Research Scholar, Stanford Center for Biomedical Ethics
Anastasiya Giarletta
Principal, R42 Fund
Gene 226 Teaching Assistant
- How are healthcare startups financed? Venture funds invest in risky companies but how do they themselves get funded, and how do they evaluate companies? How do company founders prepare for capital raising?
- How does intellectual property play? We explain both from the investor and founder viewpoints to analyze how to a) start a venture capital fund; b) present a healthcare company to a venture fund.
- We discuss financial frameworks specifically for the healthcare sector and how it differs to other segments. Additionally, guest lectures from venture capitalists, angel investors, and company founders will explain their respective perspectives.
Infectious Disease and COVID-19 Wearables Study
Can wearables help detect Infectious Disease or COVID-19 before symptoms emerge? Learn More >
J.A.
Investing in Global Health Innovations: A Decision-Making Framework
Andrew Barnett
Applying Precision Medicine to Long-Term Care Insurance
Slidedeck
Kate Buellesbach
It’s a Woman’s World: Femtech for the 21st Century
Kellyann Burlage
Venture Opportunities in Women’s Health: Closing the Gender Health Gap
Slidedeck
Cam Burton
Shifting Incentives: Exploring the future of Personalized medicine In the biotechnology industry
Pam Cai
Comparison of the investment size and returns in tech vs. biotech companies
Skyler Castillo-Wilson
Alternative Advanced Degree Funding Model for Accelerated Research and Discounted Equity Rates
Ben Conrad
Medicare Advantage: Understanding the Program & Two New Innovative Upstarts
Caroline Dunn
RETHINKING THE MENTAL HEALTH PSYCHIATRY MODEL WITH TELEMEDICINE
Slidedeck
Jacob Edelson
CRISPR Start-ups that Pivoted to COVID-19 Testing
Areian Eghball
Mental Health Thesis Making sense of a crowded space
Slidedeck
Ahmed Elbakri
Regulatory Planning and Budgeting for the Commercialization of AI-Enabled Rapid Diagnostics Platforms – A Guide for Diagnostics Entrepreneurs
Christopher Fisher
Medical Device Innovations – A review of founder and investor perspectives
Grace Catherine Benoist Fish
2021 Venture Capital Opportunities in the Mental Healthcare Space
Nicolas Garcia
Funding The “Full-Stack” Doctor – The role VC can play in the Healthcare of the Future
Slidedeck
Betty Ha
2020s The Age of Biotech
Stephanie Huang
The Roaring 20’s as the decade of biotech
Sanjay Iyer
The Role of Artificial Intelligence in Digital Health
Kathy Ku
Recents Trends in Women’s Health Consumer Brands
Esmond Lee
How universities can Bridge the Biotech Valley of Death for Cell & Gene Therapies
PJ Loury
Liquid Biopsy: Integral to the next generation of cancer treatment?
Ricardo Jacob Mack
The Relationship of Healthcare Affordability and Biotech Industry
paper
Angel Madero
Healthcare and Biotech in Latin America
Ben Marafino
Growing diseconomies of scale in pharmaceutical R&D productivity and manufacture will likely compound “payer-reluctance risk” for novel therapeutics
Vincent Masto
SPACs in biotech are here to stay
Slidedeck
Samson Joel Mataraso
Incentivizing Investment in Antibiotic Development to Tackle Rising Antibiotic Resistance
Yanick Mulumba
The role of patents in valuation of biotech companies: A case study
Floriane Ngako Kameni
Investing in Health Equity
Brandon Nydick
Evaluating Medical Device Startups: A Quantitative Framework for Venture Capitalists
Pettie Kade Ploussard
ML-guided biomolecule evolution companies are more numerous than they appear
Megan Roche, MD
Women in Venture Capital: How Underrepresentation Impacts Business And Society
Powerpoint
Slidedeck
Sarah Runkle
“We’re Not a Vitamin Company, We’re a Tech Company”
A memo for investors considering the supplements space
Jarod Rutledge
An Investment Assessment of Emerging Science in Longevity Biotechnology
Donya Sarrafian
IP Protection & the Case for 100 Year Patents
Powerpoint
Slidedeck
A.I.S.
Value-Based Pharmaceutical Pricing:
A Framework for Addressing High Drug Costs
Slidedeck
Youngyoon Amy Seo
Incyte Corporation: A venture capitalist’s dream
Slidedeck
Shannon Kayj
Creating Biological Systems Overview
Slidedeck
Diva Sharma
Healthcare Financing Companies Need A More Contrarian Approach to Scale Quicker
Slidedeck
M. T.
Optimizing the Clinical Trial
Joan E. Thompson
Gender Imbalance in Healthcare Venture Capitol:
Reviewing Market Perspectives on Arbitage & Parity
Slidedeck
Zach Walters
Precision Medicine and Mental health
Slidedeck
Victor Yin
Hong Kong Biotech IPOs
Jenna Fisher Zerker
Digital Health–A Growing Opportunity
Yihui Zhang
Funding for Cure: A Scoring Framework to Invest the Best Science
Kevin Aguirre
Uchenna Akanno
Venture Capital: The Hero or the Villain of Biotechnology Within the Black Community?
Jason Akram
Rayan Albraidi
Universal Healthcare and For – Profit Drug Development: A More Sustainable Model
Carlos Aldrete
Autologous vs. Allogeneic: Considerations for Investing in Cellular Therapeutics
Alice Artica
Where Are Investors Placing Their Bets for the Future of Healthcare Technology?
Henry Bair
Digital Health in End-of-life Care: Trends and Opportunities
Rene Caissie
Financial Models and Orphan Diseases
Laura Calderon Arango
WHY SHOULD VENTURE CAPITALISTS INVEST IN FEMTECH?
Ananya Chadha
Joshua Chan
Worth It? A Scoring Model for Autoimmune Disease Companies
Rifat Emam
Case Study: Regulations of Healthcare companies in the United States and third world countries
Gabriela Escobar
Missing the Mark. Considerations for Equity in Data-driven Health Innovatio
Jessica Frank
Venture Capital Investment Opportunit y in Direct-to-Consumer Health care Technology
Mingxin Gu
Samvel Gyurdzhyan
Financial, Start-up, and Biotech Landscape in Armenia
Trenton Hicks
An Overview of Artificial Intelligence (AI) in Healthcare
Albert Kim
Effective Venture Capital in the Augmented Reality (AR) Space
Shreya Kishore
Underrepresentation of Women of Color in Venture Capital and Founding Teams
Henry Klingenstein
2022 Venture Capital Opportunities: Autism Spectrum Disorder
Natalie Kolber
The benefits of user-focused drug development
Jeeven Larson
Unlearn – An Emerging Leader in Clinical Trial Infrastructure
Tatum La
Social Media: A Tool for Increasing Diversity in VC
Jong Ha Lee
Should healthcare & biotech startups really IPO?
Ann Lin
Founder-Led Movement and Virtual Biotech
Alex Loia
Honing the Team: A New Birth of Biomedical Ventures
Sierra Lore
The Importance of Venture Capital in Reaching the Future Potential of Genome Sequencing
Slides
Andrea Madero
What to look for in direct-to-consumer healthcare startups ?
Vilina Mehta
Investigating Pharmaceutical Drug Pricing in the US and Beyond
Wyatt Morgan
Mutational Patterns and Social Implications
Slides
Aron Nunez
Funding American Healthcare Deserts: Considerations for Investing in Rural Healthcare Startups
Slides
Neal O’Hara
Commercializing Digital Therapeutics
Slides
Scott Piper
LGBT Diversity in Healthcare Innovation and Venture Capital
Sharan Ramjee
A Machine Learning Driven Analysis of Private Equity Funding in Seed-Stage Healthcare Startups
Slides
Katie Ropers
Bias in Healthcare and the Role VC Plays in Perpetuating It
Slides
Gil Rosen
Cracking Healthcare Innovation
Joshua Sherwin
A Land of Opportunity: Healthcare Venture Capital in Mexico
Slides
kshita Singh
Investing Opportunities in Stigmatized Industries Within Women’s Health
Jun Song
How recent advances in IT can facilitate the emergence of new biotechs
Jackson Stone
Venture Studios in Biotech
Slides
Utkarsh Tandon
The Future of At-Home Medication Management
Bryce Tiglon
Aging & Epigenetic Rejuvenation: Deconstructing Neoplastic Risk with Single-Cell Science
Patrick T. Tjandra
Scaling Up Artificial Intelligence – Driven Drug Discovery Platforms
Rikhil Vagadia
Analysis of Healthcare Investing vs. Technology Investing from a Venture Capital Perspective
Pengpeng Wang
Reimagine Clinical Trials: A Patient Centric, Technology Driven Approach
Audrey Xu
Combating Biases in Healthcare VC Firms
Andy Yakulis
Building Health Technology Products for the Future: A Strategic Entrepreneurial Approach